A Legislative Inflection Point: Analyzing Colombia's Proposed Overhaul of Clinical Trial Regulations and its Strategic Implications for the Life Sciences Industry Navigating Regulatory Landscapes...
A Legislative Inflection Point: Analyzing Colombia's Proposed Overhaul of Clinical Trial Regulations and its Strategic Implications for the Life Sciences Industry Navigating Regulatory Landscapes in Latin America A new bill, Proyecto de Ley 191 , was filed on August 5, 2025, to overhaul Colombia's outdated clinical trial regulations. This legislation aims to make Colombia a more competitive hub for medical research by creating a modern, efficient, and clear legal framework. Table of Contents Overview The Old Rules: Why Change is Needed The New Bill: Key Proposed Changes What This Means for Medical Research in Colombia Conclusion Sources Overview For over 30 years, clinical research in Colombia has been governed by Resolution 8430 of 1993 . While foundational, these rules are now outdated and create significant delays, hindering medical innovation. The new bill, introduced by Senator Fabián Díaz and Representative Juan Daniel Peñuela, proposes a complete overhaul. It aims to …